Pathogenic, immunologic, and clinical aspects of sepsis - update 2016

被引:11
|
作者
Uhle, Florian [1 ]
Chousterman, Benjamin G. [2 ,3 ]
Gruetzmann, Robert [4 ]
Brenner, Thorsten [1 ]
Weber, Georg F. [4 ]
机构
[1] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany
[2] Hop Lariboisiere, AP HP, Dept Anesthesia Intens Care & SAMU, Paris, France
[3] Univ Paris Diderot, Paris, France
[4] Univ Hosp Erlangen Nurnberg, Dept Surg, Erlangen, Germany
关键词
Bacterial toxins; immune-pathophysiology; sepsis; biomarkers; microbiology; diagnostics; pathogen-host interaction; INTERNATIONAL CONSENSUS DEFINITIONS; INFLAMMATORY RESPONSE SYNDROME; GOAL-DIRECTED RESUSCITATION; NEUTROPHIL RECRUITMENT; INTENSIVE-CARE; SEPTIC SHOCK; IMMUNE-RESPONSE; HOST RESPONSE; DR EXPRESSION; THERAPY;
D O I
10.1080/14787210.2016.1224971
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Sepsis is a major cause of death worldwide but its orchestrating components remain incompletely understood. On the one hand, development of sepsis results from an infectious focus that cannot be controlled by the immune system, but on the other, responding immune cells that can eliminate the infection inflict damage to the host by contributing to complications such as endothelial leakage, septic shock, and multiorgan failure.Areas covered: In this review we give a comprehensive overview of how sepsis occurs, which exogenous and endogenous factors might affect the immune-pathophysiological course of sepsis and finally how this knowledge translates into up-to-date definitions and therapeutic approaches.Expert commentary: Although new immunological mechanisms altering the course of sepsis have been identified recently, future research needs to address the limitations of experimental approaches, redirect the research focus into translational approaches, and finally evaluate personalized treatment strategies.
引用
收藏
页码:917 / 927
页数:11
相关论文
共 50 条
  • [1] Evidence-based updates to the 2016 Surviving Sepsis Guidelines and clinical implications
    Lehman, Karen D.
    NURSE PRACTITIONER, 2019, 44 (02) : 26 - 33
  • [2] Sepsis: From Historical Aspects to Novel Vistas. Pathogenic and Therapeutic Considerations
    Magrone, Thea
    Jirillo, Emilio
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (04) : 490 - 502
  • [3] Sepsis: new findings and developments. Update 2016
    Kochanek, Matthias
    Shimabukuro-Vornhagen, Alexander
    von Bergwelt-Baildon, Michael
    Boell, Boris
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (20) : 1455 - 1458
  • [4] International guidelines from the Surviving Sepsis Campaign. 2016 update
    Briegel, J.
    Moehnle, P.
    ANAESTHESIST, 2017, 66 (07): : 530 - 538
  • [5] Update of Sepsis in the Intensive Care Unit
    Genga, Kelly Roveran
    Russell, James A.
    JOURNAL OF INNATE IMMUNITY, 2017, 9 (05) : 441 - 455
  • [6] Sepsis: An Update on Current Practices in Diagnosis and Management
    Jain, Snigdha
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2018, 356 (03) : 277 - 286
  • [7] Sepsis: update 2012
    Kochanek, M.
    Shimabukuro-Vornhagen, A.
    von Bergwelt-Baildon, M.
    Michels, G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (31-32) : 1565 - 1567
  • [8] Update in Sepsis 2012
    Russell, James A.
    Walley, Keith R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (12) : 1303 - 1307
  • [9] Sepsis: an update for physicians
    O'Callaghan, David J. P.
    Gordon, Anthony C.
    CLINICAL MEDICINE, 2011, 11 (06) : 619 - 622
  • [10] Epidemiology of sepsis: An update
    Angus, DC
    Wax, RS
    CRITICAL CARE MEDICINE, 2001, 29 (07) : S109 - S116